Intra-Graft Abciximab and Verapamil Combined with Direct Stenting is a Safe and Effective Strategy to Prevent Slow-flow and No-Reflow Phenomenon in Saphenous Vein Graft Lesions not Associated with Thrombus

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 7, Iss. 2, 2012-08 ,pp. : 152-159

Bentham Science Publishers

Access to resources Recommend Favorite

A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction

By Antoniucci D.   Rodriguez A.   Hempel A.   Valenti R.   Migliorini A.   Vigo F.   Parodi G.   Fernandez-Pereira C.   Moschi G.   Bartorelli A.   Santoro G.M.   Bolognese L.   Colombo A.  

Journal of the American College of Cardiology, Vol. 42, Iss. 11, 2003-12 ,pp. : 1879-1885

Elsevier

Access to resources Recommend Favorite

Safety of Abciximab Administration During PCI of Patients with Previous Stroke

By Deliargyris Efthymios   Upadhya Bharathi   Applegate Robert   Kontos Jimmy   Kutcher Michael   Riesmeyer Jeffrey   Sane David  

Journal of Thrombosis and Thrombolysis, Vol. 19, Iss. 3, 2005-06 ,pp. : 147-153

Springer Publishing Company

Access to resources Recommend Favorite

Safety of immediate reversal of anticoagulation by protamine to reduce bleeding complications after infarct artery stenting for acute myocardial infarction and adjunctive abciximab therapy

By Parodi Guido   Luca Giuseppe   Moschi Guia   Bellandi Benedetta   Valenti Renato   Migliorini Angela   Carrabba Nazario   Antoniucci David  

Journal of Thrombosis and Thrombolysis, Vol. 30, Iss. 4, 2010-11 ,pp. : 446-451

Springer Publishing Company

Access to resources Recommend Favorite

Rationale for intracoronary administration of abciximab

By Romagnoli Enrico   Burzotta Francesco   Trani Carlo   Biondi-Zoccai Giuseppe   Giannico Floriana   Crea Filippo  

Journal of Thrombosis and Thrombolysis, Vol. 23, Iss. 1, 2007-02 ,pp. : 57-63

Springer Publishing Company

Access to resources Recommend Favorite